Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Travis Richardson

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Heart Rhythm|April 20, 2025
Echocardiographic response from left bundle branch area pacing optimized cardiac resynchronization therapy (LOT-CRT) vs traditional CRTGaurav A Upadhyay, Marek Jastrzębski, Paul Foley, et al.
Circulation. Arrhythmia and Electrophysiology|September 27, 2022
A Mechanistic Clinical Trial Using (<i>R</i>)- Versus <i>(S</i>)-Propafenone to Test RyR2 (Ryanodine Receptor) Inhibition for the Prevention of Atrial Fibrillation InductionM Benjamin Shoemaker, Zachary T Yoneda, Diane M Crawford, et al.
Plos One|September 8, 2017
Non-pulmonary vein mediated atrial fibrillation: A novel sub-phenotypeMaureen Farrell, Zachary Yoneda, Jay Montgomery, et al.
Medrxiv : the Preprint Server for Health Sciences|September 2, 2025
Ryanodine Receptor Inhibition with Dantrolene Prevents Ventricular Tachycardia Induction in Patients with Structural Heart Disease - A Randomized Controlled TrialMajd A El-Harasis, Zachary T Yoneda, Bibin Varghese, et al.
Circulation. Arrhythmia and Electrophysiology|July 25, 2025
2-Hydroxybenzylamine for Treatment of Atrial Fibrillation: A First-in-Human Clinical Pilot TrialZachary T Yoneda, Matthew O'Neill, Diane M Crawford, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Heart Rhythm|April 20, 2025
Echocardiographic response from left bundle branch area pacing optimized cardiac resynchronization therapy (LOT-CRT) vs traditional CRTGaurav A Upadhyay, Marek Jastrzębski, Paul Foley, et al.
Circulation. Arrhythmia and Electrophysiology|September 27, 2022
A Mechanistic Clinical Trial Using (<i>R</i>)- Versus <i>(S</i>)-Propafenone to Test RyR2 (Ryanodine Receptor) Inhibition for the Prevention of Atrial Fibrillation InductionM Benjamin Shoemaker, Zachary T Yoneda, Diane M Crawford, et al.
Plos One|September 8, 2017
Non-pulmonary vein mediated atrial fibrillation: A novel sub-phenotypeMaureen Farrell, Zachary Yoneda, Jay Montgomery, et al.
Medrxiv : the Preprint Server for Health Sciences|September 2, 2025
Ryanodine Receptor Inhibition with Dantrolene Prevents Ventricular Tachycardia Induction in Patients with Structural Heart Disease - A Randomized Controlled TrialMajd A El-Harasis, Zachary T Yoneda, Bibin Varghese, et al.
Circulation. Arrhythmia and Electrophysiology|July 25, 2025
2-Hydroxybenzylamine for Treatment of Atrial Fibrillation: A First-in-Human Clinical Pilot TrialZachary T Yoneda, Matthew O'Neill, Diane M Crawford, et al.
Pageof 3